FLOT and CROSS chemotherapy regimens alter the frequency of CD27(+) and CD69(+) T cells in oesophagogastric adenocarcinomas: implications for combination with immunotherapy

Combining immunostimulatory chemotherapies with immunotherapy is an attractive strategy to enhance treatment responses in oesophagogastric junctional adenocarcinoma (OGJ). This study investigates the immunostimulatory properties of FLOT, CROSS and MAGIC chemotherapy regimens in the context of OGJ us...

Descripción completa

Detalles Bibliográficos
Autores principales: Davern, Maria, Donlon, Noel E., Sheppard, Andrew S., Majcher, Klaudia D., Connell, Fiona O’, Heeran, Aisling B., Grant, Malika, Farrell, Robert A., Hayes, Conall, Bracken-Clarke, Dara, Conroy, Melissa J., Foley, Emma, Toole, Dermot O’, Bhardwaj, Anshul, Ravi, Narayanasamy, Reynolds, John V., Maher, Stephen G., Sullivan, Jacintha O’, Lysaght, Joanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314858/
https://www.ncbi.nlm.nih.gov/pubmed/35986757
http://dx.doi.org/10.1007/s00432-022-04283-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314858/
https://www.ncbi.nlm.nih.gov/pubmed/35986757
http://dx.doi.org/10.1007/s00432-022-04283-9

Ejemplares similares